20.02.2013
- An $11 billion-plus sale of Life Technologies is looking less likely as a gap in price expectations with the company has left potential buyer Thermo Fisher Scientific skeptical...
20.02.2013
- A Paraguayan judge rejected on Tuesday a request by soy farmers to block Monsanto from collecting royalty payments for use of the biotech company's Roundup Ready seeds in the world...
18.02.2013
- Novozymes acquires Iogen Bio-Products, industrial enzyme business of Ottawa-based Iogen Corporation for CAD 67.5 million (approximately DKK 370 million) and potential earn-out...
15.02.2013
- Anergis, a company developing breakthrough allergy vaccines for fast and safe allergen-specific immunotherapy, today announced the expansion of its management team. With the...
15.02.2013
- A 75-year-old Indiana grain farmer will take on global seed giant Monsanto at the U.S. Supreme Court next week in a patent battle that could have ramifications for the...
14.02.2013
- Swiss group Actelion has raised its dividend 25% as it awaits a U.S. regulatory decision on a new heart and lung drug it hopes will cut its dependency on current mainstay Tracleer...
14.02.2013
- President Barack Obama's decision to spotlight drug rebates as a way to save money on Medicare is likely to be opposed by the pharmaceutical industry, which could potentially lose...
12.02.2013
- Novozymes Biopharma today announced a collaborative research agreement with Rhode Island-based biotech company EpiVax, to help further the development of a treatment for autoimmune...
11.02.2013
- Regeneron Pharmaceuticals said its longtime drug-development partner Sanofi aims to boost its stake in the U.S. biotechnology company through open market purchases of its stock...
07.02.2013
- Amgen said it expects generic versions of biotech drugs, known as biosimilars, to be a multibillion-dollar opportunity for the company and has targeted some of the industry's...